Literature DB >> 21990322

Dishevelled 2 signaling promotes self-renewal and tumorigenicity in human gliomas.

Teodoro Pulvirenti1, Maartje Van Der Heijden, Leif A Droms, Jason T Huse, Viviane Tabar, Alan Hall.   

Abstract

Glioblastoma multiforme is the most common glioma variant in adults and is highly malignant. Tumors are thought to harbor a subpopulation of stem-like cancer cells, with the bulk resembling neural progenitor-like cells that are unable to fully differentiate. Although multiple pathways are known to be involved in glioma tumorigenesis, the role of Wnt signaling has been poorly described. Here, we show that Dishevelled 2 (Dvl2), a key component of the Wnt signaling pathway, is overexpressed in human gliomas. RNA interference-mediated depletion of Dvl2 blocked proliferation and promoted the differentiation of cultured human glioma cell lines and primary, patient-derived glioma cells. In addition, Dvl2 depletion inhibited tumor formation after intracranial injection of glioblastoma cells in immunodeficient mice. Inhibition of canonical Wnt/β-catenin signaling also blocked proliferation, but unlike Dvl2 depletion, did not induce differentiation. Finally, Wnt5a, a noncanonical Wnt ligand, was also required for glioma cell proliferation. The data therefore suggest that both canonical and noncanonical Wnt signaling pathways downstream of Dvl2 cooperate to maintain the proliferative capacity of human glioblastomas.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21990322      PMCID: PMC3228897          DOI: 10.1158/0008-5472.CAN-11-1531

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  46 in total

Review 1.  The Wnt signaling pathway in development and disease.

Authors:  Catriona Y Logan; Roel Nusse
Journal:  Annu Rev Cell Dev Biol       Date:  2004       Impact factor: 13.827

2.  APC mutations in sporadic medulloblastomas.

Authors:  H Huang; B M Mahler-Araujo; A Sankila; L Chimelli; Y Yonekawa; P Kleihues; H Ohgaki
Journal:  Am J Pathol       Date:  2000-02       Impact factor: 4.307

3.  PDGF autocrine stimulation dedifferentiates cultured astrocytes and induces oligodendrogliomas and oligoastrocytomas from neural progenitors and astrocytes in vivo.

Authors:  C Dai; J C Celestino; Y Okada; D N Louis; G N Fuller; E C Holland
Journal:  Genes Dev       Date:  2001-08-01       Impact factor: 11.361

4.  Dvl2 promotes intestinal length and neoplasia in the ApcMin mouse model for colorectal cancer.

Authors:  Ciara Metcalfe; Ashraf E K Ibrahim; Michael Graeb; Marc de la Roche; Thomas Schwarz-Romond; Marc Fiedler; Douglas J Winton; Anthony Corfield; Mariann Bienz
Journal:  Cancer Res       Date:  2010-07-27       Impact factor: 12.701

5.  Role of Wnt pathway in medulloblastoma oncogenesis.

Authors:  Naoki Yokota; Shigeru Nishizawa; Seiji Ohta; Hiroaki Date; Haruhiko Sugimura; Hiroki Namba; Masato Maekawa
Journal:  Int J Cancer       Date:  2002-09-10       Impact factor: 7.396

6.  Activation of the Wnt pathway in non small cell lung cancer: evidence of dishevelled overexpression.

Authors:  Kazutsugu Uematsu; Biao He; Liang You; Zhidong Xu; Frank McCormick; David Mark Jablons
Journal:  Oncogene       Date:  2003-10-16       Impact factor: 9.867

7.  AXIN1 mutations but not deletions in cerebellar medulloblastomas.

Authors:  Nathalie Baeza; Jun Masuoka; Paul Kleihues; Hiroko Ohgaki
Journal:  Oncogene       Date:  2003-01-30       Impact factor: 9.867

Review 8.  Runnin' with the Dvl: proteins that associate with Dsh/Dvl and their significance to Wnt signal transduction.

Authors:  Keith A Wharton
Journal:  Dev Biol       Date:  2003-01-01       Impact factor: 3.582

9.  Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma.

Authors:  Rossella Galli; Elena Binda; Ugo Orfanelli; Barbara Cipelletti; Angela Gritti; Simona De Vitis; Roberta Fiocco; Chiara Foroni; Francesco Dimeco; Angelo Vescovi
Journal:  Cancer Res       Date:  2004-10-01       Impact factor: 12.701

10.  Wnt pathway activation in mesothelioma: evidence of Dishevelled overexpression and transcriptional activity of beta-catenin.

Authors:  Kazutsugu Uematsu; Satoshi Kanazawa; Liang You; Biao He; Zhidong Xu; Kai Li; B Matija Peterlin; Frank McCormick; David M Jablons
Journal:  Cancer Res       Date:  2003-08-01       Impact factor: 12.701

View more
  45 in total

Review 1.  Wnt/beta-catenin signaling in glioma.

Authors:  Kailiang Zhang; Junxia Zhang; Lei Han; Peiyu Pu; Chunsheng Kang
Journal:  J Neuroimmune Pharmacol       Date:  2012-03-28       Impact factor: 4.147

2.  Inhibition of WNT-CTNNB1 signaling upregulates SQSTM1 and sensitizes glioblastoma cells to autophagy blockers.

Authors:  Mireia Nàger; Marta C Sallán; Anna Visa; Charumathi Pushparaj; Maria Santacana; Anna Macià; Andrée Yeramian; Carles Cantí; Judit Herreros
Journal:  Autophagy       Date:  2018-02-21       Impact factor: 16.016

3.  Silencing dishevelled-1 sensitizes paclitaxel-resistant human ovarian cancer cells via AKT/GSK-3β/β-catenin signalling.

Authors:  Kun Zhang; Haixing Song; Ping Yang; Xiaozhen Dai; Ya Li; Lan Wang; Jun Du; Kejian Pan; Tao Zhang
Journal:  Cell Prolif       Date:  2015-01-21       Impact factor: 6.831

4.  Dosage changes of a segment at 17p13.1 lead to intellectual disability and microcephaly as a result of complex genetic interaction of multiple genes.

Authors:  Claudia M B Carvalho; Shivakumar Vasanth; Marwan Shinawi; Chad Russell; Melissa B Ramocki; Chester W Brown; Jesper Graakjaer; Anne-Bine Skytte; Angela M Vianna-Morgante; Ana C V Krepischi; Gayle S Patel; LaDonna Immken; Kyrieckos Aleck; Cynthia Lim; Sau Wai Cheung; Carla Rosenberg; Nicholas Katsanis; James R Lupski
Journal:  Am J Hum Genet       Date:  2014-11-06       Impact factor: 11.025

Review 5.  Current Understanding on EGFR and Wnt/β-Catenin Signaling in Glioma and Their Possible Crosstalk.

Authors:  Indranil Paul; Seemana Bhattacharya; Anirban Chatterjee; Mrinal K Ghosh
Journal:  Genes Cancer       Date:  2013-11

Review 6.  Brain tumor stem cells: Molecular characteristics and their impact on therapy.

Authors:  David L Schonberg; Daniel Lubelski; Tyler E Miller; Jeremy N Rich
Journal:  Mol Aspects Med       Date:  2013-07-04

Review 7.  Glioblastoma stem cells: Molecular characteristics and therapeutic implications.

Authors:  Nermin Sumru Bayin; Aram Sandaldjian Modrek; Dimitris George Placantonakis
Journal:  World J Stem Cells       Date:  2014-04-26       Impact factor: 5.326

8.  Expression of dishevelled gene in Hirschsprung's disease.

Authors:  Dong Chen; Jie Mi; Mei Wu; Weilin Wang; Hong Gao
Journal:  Int J Clin Exp Pathol       Date:  2013-08-15

9.  Identification and characterization of a small-molecule inhibitor of Wnt signaling in glioblastoma cells.

Authors:  Alessandra De Robertis; Silvia Valensin; Marco Rossi; Patrizia Tunici; Margherita Verani; Antonella De Rosa; Cinzia Giordano; Maurizio Varrone; Arianna Nencini; Carmela Pratelli; Tiziana Benicchi; Annette Bakker; Jeffrey Hill; Kanda Sangthongpitag; Vishal Pendharkar; Boping Liu; Fui Mee Ng; Siew Wen Then; Shi Jing Tai; Seong-Moon Cheong; Xi He; Andrea Caricasole; Massimiliano Salerno
Journal:  Mol Cancer Ther       Date:  2013-04-25       Impact factor: 6.261

10.  MEF promotes stemness in the pathogenesis of gliomas.

Authors:  Elena Bazzoli; Teodoro Pulvirenti; Moritz C Oberstadt; Fabiana Perna; Boyoung Wee; Nikolaus Schultz; Jason T Huse; Elena I Fomchenko; Francesca Voza; Viviane Tabar; Cameron W Brennan; Lisa M DeAngelis; Stephen D Nimer; Eric C Holland; Massimo Squatrito
Journal:  Cell Stem Cell       Date:  2012-12-07       Impact factor: 24.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.